EPA Reform Bills Considered

If passed, Republican-led efforts to change the US Environmental Protection Agency’s handling of science may never make it past the President’s desk.

Written byKerry Grens
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, DAVE_7Advisors to President Obama this week (March 3) argued in favor of vetoing two bills, backed primarily by Republicans, which are aimed at changing practices at the US Environmental Protection Agency (EPA). One of the bills would require that any actions by the agency be supported by publicly available data, while the other would overhaul its scientific advisory board.

According to a statement about the evidence transparency bill, Obama’s advisors said: “The bill would impose arbitrary, unnecessary, and expensive requirements that would seriously impede the [EPA’s] ability to use science to protect public health and the environment. . . . For example, the data underlying some scientifically-important studies is not made broadly available in order to protect the privacy of test subjects, and modeling that EPA uses for a variety of purposes are not EPA property and therefore cannot be publicly released.”

Bill supporter Dana Rohrabacher (R-CA) said there are ways around privacy issues, ScienceInsider reported: study participants could agree to have their data public, and those who don’t agree could decline to join. “Their specific participation isn’t necessary to have a successful research ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies